SAM
TMDX icon

Smartleaf Asset Management’s Transmedics TMDX Stock Holding History

Smartleaf Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.7K Sell
771
-423
-35% -$55.2K ﹤0.01% 1266
2025
Q4 		$146K Buy
1,194
+515
+76% +$64.6K 0.01% 976
2025
Q3 		$76.5K Buy
679
+131
+24% +$15.3K ﹤0.01% 1213
2025
Q2 		$72K Buy
548
+108
+25% +$11.9K 0.01% 1003
2025
Q1 		$30.2K Buy
440
+135
+44% +$9.29K ﹤0.01% 1403
2024
Q4 		$18.1K Buy
305
+248
+435% +$23.1K ﹤0.01% 1699
2024
Q3 		$9.07K Buy
57
+50
+714% +$7.7K ﹤0.01% 1814
2024
Q2 		$1.03K Buy
+7
New +$840 ﹤0.01% 2413

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Smartleaf Asset Management's TMDX Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Transmedics (TMDX) stake by 35% in Q1 2026, selling an estimated $55.2K and leaving 771 shares worth $72.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Smartleaf Asset Management first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $146K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Smartleaf Asset Management held 771 shares of Transmedics worth $72.7K as of Q1 2026.
  • Smartleaf Asset Management sold 423 Transmedics shares in Q1 2026, an estimated $55.2K.
  • Transmedics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1266 holding.
  • Smartleaf Asset Management first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Transmedics position peaked at $146K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.